UCSF

ZINC03806104

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 30 Yes

Other Names:

(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid

(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid hydrochloride monohydrate; Tirofiban HCl; Tirofiban hydrochloride monohydrate

(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid; N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine; Tirofiban

fiban

142373-60-2 (hydrochloride)

144494-65-5

144494-65-5; Agrastat (TN); D08607; Tirofiban (INN)

144494-65-5; C07965; Tirofiban

150915-40-5; Aggrastat (TN); D01029; Tirofiban hydrochloride (USAN); Tirofiban hydrochloride hydrate

151065-53-1

AC1L1U7O

AC1Q6VFB

AGG

Aggrastat

Aggrastat; C22H36N2O5S; HSDB 7323; L 700462; L-700,462; L-700462; L-Tyrosine, N-(butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-; LS-173214; MK 383; MK-383; N-(butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine; Tirofiban; Tirofiban [BAN:INN]; Tirofiban [INN:B

Agrastat

Agrastat (TN)

BIDD:GT0363

C07965

C22H36N2O5S

CHEBI:40602

CHEBI:9605

CHEMBL916

CID60947

D08607

DAP000696

DB00775

FDA)

HSDB 7323

INN)

INN); Tirofiban HCl (FDA

INN); Tirofiban HCl (USAN

L-700,462

L-700462

L-700462; MK-383

L-Tyrosine, N-(butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-

LS-173214

MFCD00868210

MFCD05237246

MFCD07368623

MK-383

N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine

N-(butylsulfonyl)-O-(4-piperidin-4-ylbutyl)-L-tyrosine

N-(BUTYLSULFONYL)-O-[4-(4-PIPERIDINYL)BUTYL]-L-TYROSINE

n-(butylsulfonyl)-o-[4-(piperidin-4-yl)butyl]-l-tyrosine

N/A

Tirofiban (BAN

Tirofiban (INN)

Tirofiban Hydrochloride

Tirofiban Hydrochloride (FDA

Tirofiban hydrochloride monohydrate

Tirofiban [BAN:INN]

Tirofiban [INN:BAN]

tirofiban; tirofibanum

TIROFIBANHYDROCHLORIDEMONOHYDRATE

tirofibanum

UNII-GGX234SI5H

USAN)

USAN); Tirofiban (BAN

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 1.98 8.66 -69.9 3 7 0 112 440.606 14
Hi High (pH 8-9.5) 3.46 6.41 -48.25 4 8 0 131 442.475 6

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 3.17e-03 g/l DrugBank-approved
Patent Database Links EP1516597; EP1574516; EP1576952; EP1743639; EP1785144; EP1810693; EP1844734; EP1992346; US2005038030; US2005043357; US2005085497; US2005096344; US2005113577; US2005124664; US2005143384; US2005187267; US2005227988; US2005267097; US2006142348; US2006142355 ChEBI
Target Others Selleck Chemicals
Patent Database Links US2002115655 ChEBI

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
ITA2B-1-E Integrin Alpha-IIb (cluster #1 Of 1), Eukaryotic Eukaryotes 9 0.38 Binding ≤ 10μM
ITB3-1-E Integrin Beta-3 (cluster #1 Of 1), Eukaryotic Eukaryotes 9 0.38 Binding ≤ 10μM
ITA2B-2-E Integrin Alpha-IIb (cluster #2 Of 2), Eukaryotic Eukaryotes 9 0.38 Functional ≤ 10μM
ITB3-1-E Integrin Beta-3 (cluster #1 Of 2), Eukaryotic Eukaryotes 9 0.38 Functional ≤ 10μM
Z50587-4-O Homo Sapiens (cluster #4 Of 9), Other Other 9 0.38 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
ITA2B_HUMAN P08514 Integrin Alpha-IIb, Human 1.9 0.41 Binding ≤ 1μM
ITB3_HUMAN P05106 Integrin Beta-3, Human 1.9 0.41 Binding ≤ 1μM
ITA2B_HUMAN P08514 Integrin Alpha-IIb, Human 1.9 0.41 Binding ≤ 10μM
ITB3_HUMAN P05106 Integrin Beta-3, Human 1.9 0.41 Binding ≤ 10μM
Z50587 Z50587 Homo Sapiens 15 0.37 Functional ≤ 10μM
ITA2B_HUMAN P08514 Integrin Alpha-IIb, Human 10 0.37 Functional ≤ 10μM
ITB3_HUMAN P05106 Integrin Beta-3, Human 10 0.37 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
ECM proteoglycans
Elastic fibre formation
GRB2:SOS provides linkage to MAPK signaling for Integrins
Integrin alphaIIb beta3 signaling
Integrin cell surface interactions
Molecules associated with elastic fibres
p130Cas linkage to MAPK signaling for integrins
PECAM1 interactions
Platelet degranulation
Signal transduction by L1
Syndecan interactions
VEGFA-VEGFR2 Pathway

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.